Spherix Sheds Consulting Business, CEO Resigns

BETHESDA, Md.  As part of a restructuring, Spherix Inc. has shed its interest in its consulting business to ChromaDex, Inc. in a stock sale.

Meantime, Spherix CEO Claire Kruger has stepped down from the top post and as a director of the scientific research company. Several directors also have resigned from the board.

Robert Clayton has taken over the top position in addition to assuming the duties of corporate secretary, Spherix announced Monday.  Spherix, based in Bethesda, Md., has been reviewing "strategic alternatives" for the business. The company said it will continue to pursue development and commercialization of its drug, food and medical technologies including food and nutritional technologies and supplements pending completion of its review.

Kruger will continue to lead the company she founded four years ago, Spherix Consulting, as a division of ChromaDex, Spherix said.

A natural products company, ChromaDex provides science-based solutions and ingredients to several industries, including the dietary supplement sector.